NO20035138D0 - Fremgangsmåte til fremstilling av amorft natriumsilastatin - Google Patents
Fremgangsmåte til fremstilling av amorft natriumsilastatinInfo
- Publication number
- NO20035138D0 NO20035138D0 NO20035138A NO20035138A NO20035138D0 NO 20035138 D0 NO20035138 D0 NO 20035138D0 NO 20035138 A NO20035138 A NO 20035138A NO 20035138 A NO20035138 A NO 20035138A NO 20035138 D0 NO20035138 D0 NO 20035138D0
- Authority
- NO
- Norway
- Prior art keywords
- silastatin
- preparation
- amorphous sodium
- amorphous
- sodium
- Prior art date
Links
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title 1
- 229910052708 sodium Inorganic materials 0.000 title 1
- 239000011734 sodium Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/02—Monohydroxylic acyclic alcohols
- C07C31/04—Methanol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/26—Separation; Purification; Stabilisation; Use of additives
- C07C319/28—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN593DE2001 | 2001-05-18 | ||
| PCT/IB2002/001696 WO2002094742A1 (en) | 2001-05-18 | 2002-05-17 | Process for the preparation of amorphous cilastatin sodium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20035138D0 true NO20035138D0 (no) | 2003-11-18 |
Family
ID=11097060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20035138A NO20035138D0 (no) | 2001-05-18 | 2003-11-18 | Fremgangsmåte til fremstilling av amorft natriumsilastatin |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20040152780A1 (et) |
| EP (1) | EP1395530A4 (et) |
| JP (1) | JP2004526805A (et) |
| KR (1) | KR20040044409A (et) |
| CN (1) | CN1522235A (et) |
| AP (2) | AP1511A (et) |
| AR (1) | AR036017A1 (et) |
| BG (1) | BG108447A (et) |
| BR (1) | BR0209843A (et) |
| CA (1) | CA2447788A1 (et) |
| CZ (1) | CZ20033352A3 (et) |
| EA (1) | EA005947B1 (et) |
| EE (1) | EE200300567A (et) |
| HR (1) | HRP20031052A2 (et) |
| HU (1) | HUP0400825A2 (et) |
| IL (1) | IL158945A0 (et) |
| MX (1) | MXPA03010547A (et) |
| NO (1) | NO20035138D0 (et) |
| NZ (1) | NZ529625A (et) |
| OA (1) | OA12607A (et) |
| PL (1) | PL367937A1 (et) |
| SK (1) | SK15082003A3 (et) |
| WO (1) | WO2002094742A1 (et) |
| ZA (1) | ZA200309287B (et) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007054771A2 (en) * | 2005-11-09 | 2007-05-18 | Orchid Chemicals & Pharmaceuticals Limited | An improved process for the preparation of cilastatin and sodium salt |
| US20120253066A1 (en) * | 2010-01-01 | 2012-10-04 | Orchid Chemicals & Pharmaceuticals Limited | Process for the preparation of cilastatin sodium |
| CN102675175B (zh) * | 2011-03-08 | 2014-02-19 | 深圳市海滨制药有限公司 | 一种西司他丁的分离纯化方法 |
| US11324804B2 (en) | 2016-11-18 | 2022-05-10 | Sepsia Therapeutics, S.L. | Combined CD6 and imipenem therapy for treatment of infectious diseases and related inflammatory processes |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5147868A (en) * | 1978-07-24 | 1992-09-15 | Merck & Co., Inc. | Thienamycin renal peptidase inhibitors |
| US4292436A (en) * | 1980-06-25 | 1981-09-29 | Merck & Co., Inc. | Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol |
| DE69106897T2 (de) * | 1990-02-08 | 1995-05-24 | Sumitomo Chemical Co | Verfahren zur Herstellung von Haloketosäureabkömmlingen. |
| US5166417A (en) * | 1990-09-04 | 1992-11-24 | Lonza Ltd. | Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid |
| CA2056840A1 (en) * | 1990-12-17 | 1992-06-18 | Thomas Meul | Process for the production of dimethylcyclopropanecarboxylic acid |
| EP0524604B1 (de) * | 1991-07-26 | 1998-10-14 | Lonza A.G. | Gentechnologisches Verfahren zur Herstellung von S-(+)-2,2-Dimethylcyclopropancarboxamid mittels Mikroorganismen |
| US5245069A (en) * | 1992-10-27 | 1993-09-14 | Merck & Co., Inc. | Process for the preparation of bis(aryl)-phosphorohalidates |
| IN191798B (et) * | 2000-11-03 | 2004-01-03 | Ranbaxy Lab Ltd |
-
2002
- 2002-05-17 CN CNA028131096A patent/CN1522235A/zh active Pending
- 2002-05-17 EP EP02727916A patent/EP1395530A4/en not_active Withdrawn
- 2002-05-17 BR BR0209843-1A patent/BR0209843A/pt not_active IP Right Cessation
- 2002-05-17 MX MXPA03010547A patent/MXPA03010547A/es not_active Application Discontinuation
- 2002-05-17 PL PL02367937A patent/PL367937A1/xx not_active Application Discontinuation
- 2002-05-17 HR HR20031052A patent/HRP20031052A2/xx not_active Application Discontinuation
- 2002-05-17 US US10/478,081 patent/US20040152780A1/en not_active Abandoned
- 2002-05-17 OA OA1200300301A patent/OA12607A/en unknown
- 2002-05-17 CZ CZ20033352A patent/CZ20033352A3/cs unknown
- 2002-05-17 CA CA002447788A patent/CA2447788A1/en not_active Abandoned
- 2002-05-17 JP JP2002591417A patent/JP2004526805A/ja not_active Withdrawn
- 2002-05-17 IL IL15894502A patent/IL158945A0/xx unknown
- 2002-05-17 KR KR10-2003-7015042A patent/KR20040044409A/ko not_active Withdrawn
- 2002-05-17 EA EA200301225A patent/EA005947B1/ru not_active IP Right Cessation
- 2002-05-17 HU HU0400825A patent/HUP0400825A2/hu unknown
- 2002-05-17 WO PCT/IB2002/001696 patent/WO2002094742A1/en not_active Ceased
- 2002-05-17 SK SK1508-2003A patent/SK15082003A3/sk unknown
- 2002-05-17 AP APAP/P/2003/002913A patent/AP1511A/en active
- 2002-05-17 AP APAP/P/2003/002912A patent/AP2003002912A0/en unknown
- 2002-05-17 NZ NZ529625A patent/NZ529625A/en unknown
- 2002-05-17 EE EEP200300567A patent/EE200300567A/et unknown
- 2002-05-20 AR ARP020101853A patent/AR036017A1/es not_active Application Discontinuation
-
2003
- 2003-11-18 NO NO20035138A patent/NO20035138D0/no not_active Application Discontinuation
- 2003-11-28 ZA ZA200309287A patent/ZA200309287B/en unknown
- 2003-12-12 BG BG108447A patent/BG108447A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040044409A (ko) | 2004-05-28 |
| AR036017A1 (es) | 2004-08-04 |
| HUP0400825A2 (hu) | 2004-08-30 |
| AP1511A (en) | 2005-12-20 |
| BG108447A (en) | 2005-03-31 |
| US20040152780A1 (en) | 2004-08-05 |
| HRP20031052A2 (en) | 2004-06-30 |
| IL158945A0 (en) | 2004-05-12 |
| CA2447788A1 (en) | 2002-11-28 |
| NZ529625A (en) | 2006-02-24 |
| ZA200309287B (en) | 2004-07-22 |
| AP2003002913A0 (en) | 2003-12-31 |
| SK15082003A3 (sk) | 2004-06-08 |
| EP1395530A1 (en) | 2004-03-10 |
| MXPA03010547A (es) | 2004-05-27 |
| OA12607A (en) | 2006-06-08 |
| WO2002094742A1 (en) | 2002-11-28 |
| BR0209843A (pt) | 2004-08-24 |
| JP2004526805A (ja) | 2004-09-02 |
| PL367937A1 (en) | 2005-03-07 |
| CZ20033352A3 (en) | 2004-06-16 |
| EA200301225A1 (ru) | 2004-06-24 |
| EE200300567A (et) | 2004-04-15 |
| CN1522235A (zh) | 2004-08-18 |
| AP2003002912A0 (en) | 2002-05-17 |
| EA005947B1 (ru) | 2005-08-25 |
| EP1395530A4 (en) | 2006-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20030012L (no) | Fremgangsmåte for fremstilling av substituerte oktanoylamider | |
| NO20042680L (no) | Fremgangsmater for fremstilling av O-demetylvenflaxine | |
| CY2007029I1 (el) | Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων | |
| FI20011578A0 (fi) | Menetelmä puhtaan sitalopraamin valmistamiseksi | |
| NO20013943D0 (no) | Fremgangsmate for fremstilling av Citalopram | |
| NO20040027L (no) | Fremgangsmate for fremstillingen av escitalopram | |
| NO20030163L (no) | Fremgangsmate for fremstilling av olefiner | |
| NO20040278L (no) | Fremgangsmate for fremstilling av perindopril | |
| FI20011541A0 (fi) | Menetelmä massan valmistamiseksi | |
| NO20032731D0 (no) | Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner | |
| NO20044814L (no) | Fremgangsmate for fremstilling av combretastaniner | |
| NO20041850L (no) | Fremgangsmate for dannelse av profenkrystaller | |
| NO20034003D0 (no) | Fremgangsmåte for fremstilling av imidazol-forbindelser | |
| NO20035538D0 (no) | Fremgangsmåte for fremstilling av zaleplon | |
| NO20023445L (no) | Fremgangsmåte for fremstilling av peptider | |
| NO20025423L (no) | Fremgangsmate for fremstilling av Citalopram | |
| NO20030515D0 (no) | Fremgangsmåte for fremstilling av dinapsolin | |
| NO20035586D0 (no) | Fremgangsmåte for fremstilling av cykloheksanol-derivater | |
| NO20035136D0 (no) | Fremgangsmåte til fremstilling av imipenem | |
| NO20021118D0 (no) | Fremgangsmåte for fremstilling av citalopram | |
| NO20035138D0 (no) | Fremgangsmåte til fremstilling av amorft natriumsilastatin | |
| NO20025703L (no) | Fremgangsmåte for fremstilling av vannfritt natriumperklorat | |
| NO20024887L (no) | FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser | |
| NO20023702D0 (no) | Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder | |
| NO20040485L (no) | Fremgangsmåte til fremstilling av amorf form av torsemid. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |